RT Journal Article
SR Electronic
A1 Gordon, Debra
T1 The Role of Newer Anticoagulants in the Treatment of Atrial Fibrillation
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 28
OP 29
DO 10.1177/155989771010019
UL http://mdc.sagepub.com/content/10/10/28.abstract
AB Stroke prevention in atrial fibrillation is an evolving story and it is often predicted that the he new oral anticoagulants that are now reaching the market offer numerous advantages over vitamin K antagonists, including oral administration, therapeutic stability that does not require monitoring, once- or twice-daily administration, and a short half-life.